- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Caraco Pharmaceutical Labortories Ltd. (CPD)
by latest | most commented
-
Contrarian Stock Screen: Biggest Losers in 2009
-
Monday's Closing Update
-
Russell Indexing Reshuffle Moves Healthcare Stocks: CXM, CTIC, HEB, CPD
-
Friday's Closing Update
-
FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, HLUKY
-
Caraco Pharma Poised for a Turnaround
-
Three Oversold Healthcare Catalyst Stocks
-
Biotech Going Generic Like Big Pharma?
-
Caraco Pharma Awaits FDA Inspection in May
-
A 130/30 Generic Pharma Trading Strategy
-
Interested in Small-Cap Generic Drugs? Keep an Eye on Caraco Pharma
-
Hi-Tech Pharmacal: High Growth at a Value Price
-
Six Sectors Presenting Opportunities as Obama Takes Office
-
In Search of Healthcare Diamonds in the Rough
-
20 Emerging Healthcare Stocks to Watch in '09
-
Nine for '09 Picks Start Strong
-
Five Healthcare Stocks Positioned for a Happy New Year
-
Small, Defensive 2009 Stock Picks Are Soaring
-
Home Diagnostics Offers Value to Investors as Well as Diabetics
-
Nine for '09: Staying Defensive in the New Year
-
Taro Pharma Tender Raises Questions About Rival Company Valuations
-
Looking for Laggards After the Latest Market Rally
-
Investment Ideas That Stand Out from ETF Innovators New Indexes
-
AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA
-
Caraco Pharma Is a Compelling Value at This Price
-
Investing in India's Generic Drug Market
-
10 Micro and Small Cap Healthcare Value Stocks Currently Under the Radar
-
Ortho-McNeil's Formulation Patent on Ultracet Declared Invalid
-
Federal Circuit Rules in Favor of Forest in Dispute with Caraco over Lexapro
-
Caraco Pharmaceutical Laboratories: Fast Grower
-
Caraco Wins Appeal Over Ortho-McNeil